Features
The reaction from the pharmaceutical industry has been mixed since the announcement of serialisation requirements. Ben Hargreaves...
With the New Year begun in earnest, Pharmafocus speaks to a range of players in pharma and the life sciences to find out what 2017 meant...
With the technologies reaching exciting levels of maturity and adoption, Matt Fellows investigates how AI and machine learning can be...
Pharmafile.com met with Marco Avila, Vice President of Medical Affairs at Teva Europe to discuss his life in the industry, his work ethics and...
Andrew Blevins and Andrew Carrington of Liberty Property Trust and Countryside Properties explain how organisations at the Cambridge Biomedical...
Michael Adeogun, Head of Life Sciences and Health at National Physical Laboratory, discusses the importance of effective measurement for the life...
As industry discourse continues to discuss how real world evidence can be transformative for the regulatory landscape, Jacqueline Corrigan-Curay...
Real world evidence is high on the agenda at many conferences, as people mull over the possibilities that it may hold for changing the way we...
As the pharmaceutical industry places increasing weight on the importance of patient-reported outcomes in securing approvals, Ben Hargreaves...
What will be the key industry trends in 2018? Here at Pharmafile, we look ahead to what we expect could be some of the major trends that will...
